Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction

By Flores M.  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 917-928

Springer Publishing Company

Access to resources Recommend Favorite

The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 389-394

Spandidos Publications

Access to resources Recommend Favorite

Treatment of prostate and breast tumors employing mono- and bi-specific antisense oligonucleotides targeting apoptosis inhibitory proteins clusterin and bcl-2

By Rubenstein Marvin   Tsui Paulus   Guinan Patrick  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 592-599

Humana Press, Inc

Access to resources Recommend Favorite

Increased prostate-specific membrane antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against bcl-2 and EGFR

By Rubenstein Marvin  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1212-1218

Humana Press, Inc

Access to resources Recommend Favorite

Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells

By            

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1271-1277

Spandidos Publications

Access to resources Recommend Favorite